Charlottesville, VA, United States of America

Kiel Douglas Neumann

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Kiel Douglas Neumann

Introduction

Kiel Douglas Neumann is an accomplished inventor based in Charlottesville, VA (US). He has made significant contributions to the field of medical technology, particularly in the development of imageable radioisotopes. With a total of 2 patents, his work has the potential to impact therapeutic applications in medicine.

Latest Patents

Neumann's latest patents focus on particles functionalized with imageable radioisotopes and methods of making and using them. These innovations relate to imageable radioisotopic microspheres, which are radiolabeled with imageable radioisotopes. In some embodiments, the imageable radioisotope is directly coupled to the surface of a substrate of the microsphere. These imageable microspheres can serve as surrogate particles to predict the distribution of therapeutic microspheres that comprise radiotherapeutic isotopes.

Career Highlights

Throughout his career, Kiel Douglas Neumann has worked with notable organizations such as Boston Scientific Medical Device Limited and the University of Virginia. His experience in these institutions has allowed him to refine his expertise in medical devices and innovative technologies.

Collaborations

Neumann has collaborated with several professionals in his field, including James R. Stone and Matthew R. Dreher. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Kiel Douglas Neumann's work in the field of imageable radioisotopes showcases his innovative spirit and dedication to advancing medical technology. His contributions are poised to make a significant impact on therapeutic applications in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…